Clinical Trial: Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535775) titled 'Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers' on March 31.

Brief Summary: The goal of this study is to evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 after Single Subcutaneous Injection in Healthy Chinese Volunteers

Study Start Date: May 06

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: BCD-261

Anti-TL1A human monoclonal antibody. Solution for Subcutaneous Injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: SPH-BIOCAD (HK) Limited

Discl...